References
- World Health Organization, A global brief on hypertension: Silent killer, global public health crisis: World Health Day 2013, WHO, Geneva, Switzerland, 2013. Available at https://www.who.int/campaigns/world-health-day/2013/campaign_essentials.pdf.
- R. Gupta and S. Guptha, Strategies for initial management of hypertension, Indian J. Med. Res. 132 (2010), pp. 531.
- J. Morgado, B. Sanches, R. Anjos, and C. Coelho, Programming of essential hypertension: What pediatric cardiologists need to know, Pediatr. Cardiol. 36 (2015), pp. 1327–1337. doi:https://doi.org/10.1007/s00246-015-1204-7.
- M. Singh, A. Singh, P. Pandey, S. Chandra, K. Singh, and I. Gambhir, Molecular genetics of essential hypertension, Clin. Exp. Hypertens. 38 (2016), pp. 268–277. doi:https://doi.org/10.3109/10641963.2015.1116543.
- P.B. Munroe, M.R. Barnes, and M.J. Caulfield, Advances in blood pressure genomics, Circ. Res. 12 (2013), pp. 1365–1379. doi:https://doi.org/10.1161/CIRCRESAHA.112.300387.
- F.H. Wilson, S. Disse-Nicodeme, K.A. Choate, K. Ishikawa, C. Nelson-Williams, I. Desitter, M. Gunel, D.V. Milford, G.W. Lipkin, and J.-M. Achard, Human hypertension caused by mutations in WNK kinases, Science 293 (2001), pp. 1107–1112. doi:https://doi.org/10.1126/science.1062844.
- M.R. Weir and V.J. Dzau, The renin-angiotensin-aldosterone system: A specific target for hypertension management, Am. J. Hypertens. 12 (1999), pp. 205S–213S. doi:https://doi.org/10.1016/S0895-7061(99)00103-X.
- B.-E. Xu, J.M. English, J.L. Wilsbacher, S. Stippec, E.J. Goldsmith, and M.H. Cobb, WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II, J. Biol. Chem. 275 (2000), pp. 16795–16801. doi:https://doi.org/10.1074/jbc.275.22.16795.
- X. Min, B.-H. Lee, M.H. Cobb, and E.J. Goldsmith, Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension, Structure 12 (2004), pp. 1303–1311. doi:https://doi.org/10.1016/j.str.2004.04.014.
- T. Moriguchi, S. Urushiyama, N. Hisamoto, S.-I. Iemura, S. Uchida, T. Natsume, K. Matsumoto, and H. Shibuya, WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1, J. Biol. Chem. 280 (2005), pp. 42685–42693. doi:https://doi.org/10.1074/jbc.M510042200.
- D.R. Alessi, J. Zhang, A. Khanna, T. Hochdörfer, Y. Shang, and K.T. Kahle, The WNK-SPAK/OSR1 pathway: Master regulator of cation-chloride cotransporters, Sci. Signal. 7 (2014), pp. re3–re3. doi:https://doi.org/10.1126/scisignal.2005365.
- B.M. Filippi, P. De Los Heros, Y. Mehellou, I. Navratilova, R. Gourlay, M. Deak, L. Plater, R. Toth, E. Zeqiraj, and D.R. Alessi, MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases, EMBO J. 30 (2011), pp. 1730–1741. doi:https://doi.org/10.1038/emboj.2011.78.
- F. Veríssimo and P. Jordan, WNK kinases, a novel protein kinase subfamily in multi-cellular organisms, Oncogene 20 (2001), pp. 5562. doi:https://doi.org/10.1038/sj.onc.1204726.
- P. de Los Heros, K.T. Kahle, J. Rinehart, N.A. Bobadilla, N. Vázquez, P. San Cristobal, D.B. Mount, R.P. Lifton, S.C. Hebert, and G. Gamba, WNK3 bypasses the tonicity requirement for K-Cl cotransporter activation via a phosphatase-dependent pathway, Proc. Natl. Acad. Sci. U.S.A. 103 (2006), pp. 1976–1981. doi:https://doi.org/10.1073/pnas.0510947103.
- J. Rinehart, K.T. Kahle, P. de Los Heros, N. Vazquez, P. Meade, F.H. Wilson, S.C. Hebert, I. Gimenez, G. Gamba, and R.P. Lifton, WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-Cl-cotransporters required for normal blood pressure homeostasis, Proc. Natl. Acad. Sci. U.S.A. 102 (2005), pp. 16777–16782. doi:https://doi.org/10.1073/pnas.0508303102.
- J.A. McCormick and D.H. Ellison, The WNKs: A typical protein kinases with pleiotropic actions, Physiol. Rev. 91 (2011), pp. 177–219. doi:https://doi.org/10.1152/physrev.00017.2010.
- K. Yamada, H.-M. Park, D.F. Rigel, K. DiPetrillo, E.J. Whalen, A. Anisowicz, M. Beil, J. Berstler, C.E. Brocklehurst, and D.A. Burdick, Small-molecule WNK inhibition regulates cardiovascular and renal function, Nat. Chem. Biol. 12 (2016), pp. 896–898. doi:https://doi.org/10.1038/nchembio.2168.
- R. Roy, M.F. Sk, N.A. Jonniya, S. Poddar, and P. Kar, Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies, J. Biomol. Struct. Dyn. (2021). doi:https://doi.org/10.1080/07391102.2021.1897680.
- M.I. Hassan, V. Kumar, T.P. Singh, and S. Yadav, Structural model of human PSA: A target for prostate cancer therapy, Chem. Biol. Drug Des. 70 (2007), pp. 261–267. doi:https://doi.org/10.1111/j.1747-0285.2007.00553.x.
- P. Khan, A. Queen, T. Mohammad, Smita, N.S. Khan, Z.B. Hafeez, M.I. Hassan, and S. Ali, Identification of α-mangostin as a potential inhibitor of microtubule affinity regulating kinase 4, J. Nat. Prod. 82 (2019), pp. 2252–2261. doi:https://doi.org/10.1021/acs.jnatprod.9b00372.
- T. Mohammad, S. Batra, R. Dahiya, M.H. Baig, I.A. Rather, -J.-J. Dong, and I. Hassan, Identification of high-affinity inhibitors of cyclin-dependent kinase 2 towards anticancer therapy, Molecules 24 (2019), pp. 4589. doi:https://doi.org/10.3390/molecules24244589.
- M. Shekarabi, J. Zhang, A.R. Khanna, D.H. Ellison, E. Delpire, and K.T. Kahle, WNK kinase signaling in ion homeostasis and human disease, Cell Metab. 25 (2017), pp. 285–299. doi:https://doi.org/10.1016/j.cmet.2017.01.007.
- N.A. Jonniya, M.F. Sk, and P. Kar, Investigating phosphorylation-induced conformational changes in WNK1 kinase by molecular dynamics simulations, ACS Omega 4 (2019), pp. 17404–17416. doi:https://doi.org/10.1021/acsomega.9b02187.
- T. Mohammad, S. Siddiqui, A. Shamsi, M.F. Alajmi, A. Hussain, A. Islam, F. Ahmad, and M. Hassan, Virtual screening approach to identify high-affinity inhibitors of serum and glucocorticoid-regulated kinase 1 among bioactive natural products: Combined molecular docking and simulation studies, Molecules 25 (2020), pp. 823. doi:https://doi.org/10.3390/molecules25040823.
- D.S. Jairajpuri, T. Mohammad, K. Adhikari, P. Gupta, G.M. Hasan, M.F. Alajmi, M.T. Rehman, A. Hussain, and M.I. Hassan, Identification of sphingosine kinase-1 inhibitors from bioactive natural products targeting cancer therapy, ACS Omega 5 (2020), pp. 14720–14729. doi:https://doi.org/10.1021/acsomega.0c01511.
- D.A. Case, I.Y. Ben-Shalom, S.R. Brozell, D.S. Cerutti, I.T.E. Cheatham, V.W.D. Cruzeiro, T.A. Darden, R.E. Duke, D. Ghoreishi, M.K. Gilson, H. Gohlke, A.W. Goetz, D. Greene, R. Harris, N. Homeyer, Y. Huang, S. Izadi, A. Kovalenko, T. Kurtzman, T.S. Lee, S. LeGrand, P. Li, C. Lin, J. Liu, T. Luchko, R. Luo, D.J. Mermelstein, K.M. Merz, Y. Miao, G. Monard, C. Nguyen, H. Nguyen, I. Omelyan, A. Onufriev, F. Pan, R. Qi, D.R. Roe, A. Roitberg, C. Sagui, S. Schott-Verdugo, J. Shen, C.L. Simmerling, J. Smith, R. SalomonFerrer, J. Swails, R.C. Walker, J. Wang, H. Wei, R.M. Wolf, X. Wu, L. Xiao, D.M. York, and P.A. Kollman, Amber 2018, University of California, San Francisco, 2018.
- N. Homeyer, A.H. Horn, H. Lanig, and H. Sticht, AMBER force-field parameters for phosphorylated amino acids in different protonation states: Phosphoserine, phosphothreonine, phosphotyrosine, and phosphohistidine, J. Mol. Model. 12 (2006), pp. 281–289. doi:https://doi.org/10.1007/s00894-005-0028-4.
- G.M. Sastry, M. Adzhigirey, T. Day, R. Annabhimoju, and W. Sherman, Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments, J. Comput. Aided Mol. Des. 27 (2013), pp. 221–234. doi:https://doi.org/10.1007/s10822-013-9644-8.
- E. Harder, W. Damm, J. Maple, C. Wu, M. Reboul, J.Y. Xiang, L. Wang, D. Lupyan, M.K. Dahlgren, and J.L. Knight, OPLS3: A force field providing broad coverage of drug-like small molecules and proteins, J. Chem. Theory Comput. 12 (2016), pp. 281–296. doi:https://doi.org/10.1021/acs.jctc.5b00864.
- T.A. Halgren, R.B. Murphy, R.A. Friesner, H.S. Beard, L.L. Frye, W.T. Pollard, and J.L. Banks, Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening, J. Med. Chem. 47 (2004), pp. 1750–1759. doi:https://doi.org/10.1021/jm030644s.
- R.A. Friesner, R.B. Murphy, M.P. Repasky, L.L. Frye, J.R. Greenwood, T.A. Halgren, P.C. Sanschagrin, and D.T. Mainz, Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein− ligand complexes, J. Med. Chem. 49 (2006), pp. 6177–6196. doi:https://doi.org/10.1021/jm051256o.
- D.E. Pires, T.L. Blundell, and D.B. Ascher, pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures, J. Med. Chem. 58 (2015), pp. 4066–4072. doi:https://doi.org/10.1021/acs.jmedchem.5b00104.
- P. Banerjee, A.O. Eckert, A.K. Schrey, and R. Preer, ProTox-II: A webserver for the prediction of toxicity of chemicals, Nucleic Acids Res. 46 (2018), pp. W257–W263. doi:https://doi.org/10.1093/nar/gky318.
- J.A. Maier, C. Martinez, K. Kasavajhala, L. Wickstrom, K.E. Hauser, and C. Simmerling, ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB, J. Chem. Theory Comput. 11 (2015), pp. 3696–3713. doi:https://doi.org/10.1021/acs.jctc.5b00255.
- J. Wang, R.M. Wolf, J.W. Caldwell, P.A. Kollman, and D.A. Case, Development and testing of a general amber force field, J. Comput. Chem. 25 (2004), pp. 1157–1174. doi:https://doi.org/10.1002/jcc.20035.
- D.J. Price and C.L. Brooks III, A modified TIP3P water potential for simulation with Ewald summation, J. Chem. Phys. 121 (2004), pp. 10096–10103. doi:https://doi.org/10.1063/1.1808117.
- V. Kräutler, W.F. Van Gunsteren, and P.H. Hünenberger, A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations, J. Comput. Chem. 22 (2001), pp. 501–508. doi:https://doi.org/10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V.
- T. Darden, D. York, and L. Pedersen, Particle mesh Ewald: An N.log(N) method for Ewald sums in large systems, J. Chem. Phys. 98 (1993), pp. 10089–10092. doi:https://doi.org/10.1063/1.464397.
- R.W. Pastor, B.R. Brooks, and A. Szabo, An analysis of the accuracy of Langevin and molecular dynamics algorithms, Mol. Phys. 65 (1988), pp. 1409–1419. doi:https://doi.org/10.1080/00268978800101881.
- R.J. Loncharich, B.R. Brooks, and R.W. Pastor, Langevin dynamics of peptides: The frictional dependence of isomerization rates of N‐acetylalanyl‐N′‐methylamide, Biopolymers 32 (1992), pp. 523–535. doi:https://doi.org/10.1002/bip.360320508.
- H.J. Berendsen, J.V. Postma, W.F. van Gunsteren, A. DiNola, and J. Haak, Molecular dynamics with coupling to an external bath, J. Chem. Phys. 81 (1984), pp. 3684–3690. doi:https://doi.org/10.1063/1.448118.
- D.R. Roe and T.E. Cheatham III, PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data, J. Chem. Theory Comput. 9 (2013), pp. 3084–3095. doi:https://doi.org/10.1021/ct400341p.
- R. Roy, B. Ghosh, and P. Kar, Investigating conformational dynamics of Lewis Y oligosaccharides and elucidating blood group dependency of cholera using molecular dynamics, ACS Omega 5 (2020), pp. 3932–3942. doi:https://doi.org/10.1021/acsomega.9b03398.
- R. Roy, A. Mishra, S. Poddar, D. Nayak, and P. Kar, Investigating the mechanism of recognition and structural dynamics of nucleoprotein-RNA complex from Peste des petits ruminants virus via Gaussian accelerated molecular dynamics simulations, J. Biomol. Struct. Dyn. (2020), pp. 1–14. doi:https://doi.org/10.1080/07391102.2020.1838327.
- N.A. Jonniya and P. Kar, Investigating specificity of the anti-hypertensive inhibitor WNK463 against With-No-Lysine kinase family isoforms via multiscale simulations, J. Biomol. Struct. Dyn. 38 (2020), pp. 1306–1321. doi:https://doi.org/10.1080/07391102.2019.1602079.
- N.A. Jonniya, M.F. Sk, and P. Kar, A comparative study of structural and conformational properties of WNK kinase isoforms bound to an inhibitor: Insights from molecular dynamic simulations, J. Biomol. Struct. Dyn. (2020), pp. 1–16. doi:https://doi.org/10.1080/07391102.2020.1827035.
- N.A. Jonniya, M.F. Sk, and P. Kar, Characterizing allosteric inhibitor-induced inactive state in With-No-Lysine kinase 1 using Gaussian accelerated molecular dynamic simulations, Phys. Chem. Chem. Phys. 23 (2021), pp. 7343–7358. doi:https://doi.org/10.1039/D0CP05733A.
- M.F. Sk, N.A. Jonniya, and P. Kar, Exploring the energetic basis of binding of currently used drugs against HIV-1 subtype CRF01_AE protease via molecular dynamics simulations, J. Biomol. Struct. Dyn. 39 (2020), pp. 5892–5909. doi:https://doi.org/10.1080/07391102.2020.1794965.
- M.F. Sk, N.A. Jonniya, R. Roy, S. Poddar, and P. Kar, Computational investigation of structural dynamics of SARS-CoV-2 methyltransferase-stimulatory factor heterodimer nsp16/nsp10 bound to the cofactor SAM, Front. Mol. Biosci. 7 (2020), pp. 353. doi:https://doi.org/10.3389/fmolb.2020.590165.
- M.F. Sk, R. Roy, N.A. Jonniya, S. Poddar, and P. Kar, Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations, J. Biomol. Struct. Dyn. 39 (2020), pp. 3649–3661. doi:https://doi.org/10.1080/07391102.2020.1768149.
- M.F. Sk, R. Roy, and P. Kar, Exploring the potency of currently used drugs against HIV-1 protease of subtype D variant by using multiscale simulations, J. Biomol. Struct. Dyn. 39 (2020), pp. 988–1003. doi:https://doi.org/10.1080/07391102.2020.1724196.
- N.A. Jonniya, M.F. Sk, and P. Kar, Elucidating specificity of an allosteric inhibitor WNK476 among With‐No‐Lysine kinase isoforms using molecular dynamic simulations, Chem. Biol. Drug Des. 98 (2021), pp. 405–420. doi:https://doi.org/10.1111/cbdd.13863.
- P. Kar, M. Seel, U.H. Hansmann, and S. Höfinger, Dispersion terms and analysis of size-and charge dependence in an enhanced Poisson− Boltzmann approach, J. Phys. Chem. B 111 (2007), pp. 8910–8918. doi:https://doi.org/10.1021/jp072302u.
- P. Kar, Y. Wei, U.H. Hansmann, and S. Höfinger, Systematic study of the boundary composition in Poisson Boltzmann calculations, J. Comput. Chem. 28 (2007), pp. 2538–2544. doi:https://doi.org/10.1002/jcc.20698.
- J. Wang, W. Wang, P.A. Kollman, and D.A. Case, Automatic atom type and bond type perception in molecular mechanical calculations, J. Mol. Graphics Modell. 25 (2006), pp. 247–260. doi:https://doi.org/10.1016/j.jmgm.2005.12.005.
- H. Gohlke, C. Kiel, and D.A. Case, Insights into protein–protein binding by binding free energy calculation and free energy decomposition for the Ras–Raf and Ras–RalGDS complexes, J. Mol. Biol. 330 (2003), pp. 891–913. doi:https://doi.org/10.1016/S0022-2836(03)00610-7.
- N. Saito, Y. Tada, T. Okabe, and T. Nagano, Docking simulation of fragment library compounds to find new leads for specific WNK kinase inhibitors, Chem-Bio Inf. J. 17 (2017), pp. 30–33.
- T.W. Backman, Y. Cao, and T. Girke, ChemMine tools: An online service for analyzing and clustering small molecules, Nucleic Acids Res. 39 (2011), pp. W486–W491. doi:https://doi.org/10.1093/nar/gkr320.
- J. Ekowati, N.W. Diyah, K.A. Nofianti, and I.S. Hamid, Molecular docking of ferulic acid derivatives on P2Y12 receptor and their ADMET prediction, J. Math. Fundam. Sci. 50 (2018), pp. 203–219. doi:https://doi.org/10.5614/j.math.fund.sci.2018.50.2.8.
- F.I. Khan, M. Aamir, D.-Q. Wei, F. Ahmad, and M.I. Hassan, Molecular mechanism of Ras-related protein Rab-5A and effect of mutations in the catalytically active phosphate-binding loop, J. Biomol. Struct. Dyn. 35 (2017), pp. 105–118. doi:https://doi.org/10.1080/07391102.2015.1134346.
- F.I. Khan, M. Shahbaaz, K. Bisetty, A. Waheed, W.S. Sly, F. Ahmad, and M.I. Hassan, Large scale analysis of the mutational landscape in β-glucuronidase: A major player of mucopolysaccharidosis type VII, Gene 576 (2016), pp. 36–44. doi:https://doi.org/10.1016/j.gene.2015.09.062.
- A. Ito, A. Mukaiyama, Y. Itoh, H. Nagase, I.B. Thøgersen, J.J. Enghild, Y. Sasaguri, and Y. Mori, Degradation of interleukin 1β by matrix metalloproteinases, J. Biol. Chem. 271 (1996), pp. 14657–14660. doi:https://doi.org/10.1074/jbc.271.25.14657.
- F. Rodier, R.P. Bahadur, P. Chakrabarti, and J. Janin, Hydration of protein–protein interfaces, Proteins Struct. Funct. Bioinf. 60 (2005), pp. 36–45. doi:https://doi.org/10.1002/prot.20478.
- R.E. Hubbard and M.K. Haider, Hydrogen bonds in proteins: Role and strength, in Encyclopedia of Life Sciences (eLS), John Wiley & Sons, Ltd, Chichester, 2010. doi:https://doi.org/10.1002/9780470015902.a0003011.pub2.